onesawava.wordpress.com
The Coral Gables-based privately held dermatology companyg said it will acquirwe all sharesof France-based ABR Invent and ABR Development through a definitiv e stock purchase agreement. "Stiefel Laboratories has been lookin for the right dermal filler to add to our aesthetixc portfolio for quite some Stiefel Chairman and Chief Executive OfficerCharles W. Stiefel said in a news release. "Afted conducting due diligence andextensive research, our team made an offed to ABR Development, a company whose innovation, expertise and productf portfolio will significantly strengthen our position in the globaol aesthetics market.
" Atlean dermal filler is currently sold in Francre and Italy, and Stiefel said distribution and manufacturing agreementa for the product will remain in place throughout Europe. All sales representatives formerly employed by ABR Development will now becomse employees ofStiefel Laboratories. Stiefel said it plana to launch the dermal filler in partaof Europe, Asia Pacific, Latin Americ a and the Caribbean over the next year and a half. The companu said it will continue clinical development of Atlea n dermal filler in order to submig the product for approval from the Food and Drug Administrationb and other regulatory bodies aroundthe world.
Stiefe also expects to develop other productsx from theABR portfolio.
ليست هناك تعليقات:
إرسال تعليق